|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/39541 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 31/4406 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 31/4406 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3270966 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16769460.3 |
| Date of filing the European patent application | 2016-03-18 | |
| (97) | Date of publication of the European application | 2018-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/023298 |
| Date | 2016-03-18 |
| (87) | Number | WO 2016/154068 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 201562136303 P | 2015-03-20 | US | |
| 201562137601 P | 2015-03-24 | US |
| (72) |
GOODENOW, Robert , US
ORDENTLICH, Peter , US
|
| (73) |
Syndax Pharmaceuticals, Inc. ,
35 Gatehouse Drive
Building D, Floor 3, Waltham, Massachusetts 02451,
US
|
| (54) | COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE. |
| COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE. |